Philips has unveiled Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems, delivering significant advancements in artificial intelligence integration and image quality enhancement.
Scientists have engineered a portable 3D printing device that produces bone grafts directly onto fractures during surgery. The technology enables real-time fabrication of customised implants without pre-operative preparation, whilst incorporating antibiotics to prevent infection and promoting natural bone regeneration at the grafting site.
GE HealthCare has announced the launch of its most advanced cardiovascular ultrasound system, the Vivid Pioneer, featuring next-generation AI automation and enhanced imaging capabilities designed to transform cardiac diagnostic workflows. The ultra-premium system has received both CE Mark approval and U.S. FDA 510(k) clearance, positioning it for global deployment in cardiovascular care settings.
Phraxis, Inc. has successfully completed the world’s first commercial case using its FDA-approved EndoForceAnastomotic Connector, establishing a pivotal milestone in dialysis vascular access innovation. The groundbreaking procedure, performed at Spartanburg Regional Medical Center in South Carolina, signals the beginning of U.S. commercialisation for this novel endovascular device designed to standardise arteriovenous graft creation.
Abbott has received CE mark approval in Europe for an expanded indication of its Navitor™ transcatheter aortic valve implantation (TAVI) system, significantly broadening treatment options for patients with symptomatic, severe aortic stenosis. The minimally invasive device is now approved for patients at low or intermediate surgical risk, complementing its existing approval for high and extreme-risk […]
Comprehensive cardiac monitoring reveals that low aerobic fitness and advancing age independently drive irregular heartbeat patterns previously dismissed as benign, with implications for preventive screening strategies starting at age 50.
Researchers from the International Brain Laboratory have unveiled the first brain-wide activity map showing how decision-making unfolds across the entire brain in mice at single-cell resolution. The comprehensive study recorded from over 621,000 neurons across 279 brain areas, revealing that decision-making is distributed across many regions in a highly coordinated way.
A major international clinical trial has overturned four decades of standard cardiac care, finding that beta-blockers provide no benefit for most heart attack survivors with preserved heart function. The REBOOT study, involving over 8,500 patients, could reshape treatment guidelines worldwide.
The Society of Nuclear Medicine and Molecular Imaging has unveiled a comprehensive digital platform designed to streamline patient access to radiopharmaceutical clinical trials. The Global Radiopharmaceutical Trial Finder utilises artificial intelligence to match patients, physicians, and researchers with relevant studies across multiple international registries, addressing critical gaps in clinical trial participation rates.
A groundbreaking diagnostic test measuring brain blood flow dynamics has demonstrated superior accuracy in detecting Alzheimer’s disease compared to traditional markers, achieving a 96% diagnostic performance rate. The non-invasive cerebrovascular test offers hope for earlier, more accessible dementia screening whilst challenging conventional amyloid-focused diagnostic approaches.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
